Stamford, CT -- (SBWIRE) -- 01/15/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: STEM CELL THERAPEUTI (OTCMKTS:SCTPF), Chromadex Corp (OTCMKTS:CDXC), Axxess Pharma Inc (OTCMKTS:AXXE), Gray Fox Petroleum Corp (OTCBB:GFOX)
STEM CELL THERAPEUTI (OTCMKTS:SCTPF) opened the session at $0.45, trading in a range of $0.43 - $0.54. The stock showed a positive performance of +13.47% in the last trading session from its previous close of $0.4477 and closed at $0.508. The stock traded on a volume of 1.00 million shares and the average volume of the stock remained 196,499 shares. Stem Cell Therapeutics Corp., a biopharmaceutical development company, develops and commercializes stem cell-based therapies for cell therapy and regenerative medicine. Its products include Tigecycline, which is in phase I for study in patients with relapsed or refractory acute myeloid leukemia (AML); SIRPaFc, an antagonist of the CD47- SIRPa interaction to alleviate CD47-mediated suppression and promote anti-tumour responses.
For How Long SCTPF will Fight for Profitability? Read This Trend Analysis report
Chromadex Corp (OTCMKTS:CDXC) traded 310,106 shares in the last business day while the average volume of the stock remained 286,990 shares. The stock showed a positive movement of +13.31% to end at $1.78. The 52 week range of the stock remained $0.50 - $1.83. Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company’s products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries. The Company together with its subsidiaries supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of potential attributes, and reference materials, related contract services, technical consulting and ingredients.
For How Long CDXC’s Gloss will Attract Investors? Find out via this report
Axxess Pharma Inc (OTCMKTS:AXXE) reported 2.41 million shares were exchanged during the last trade, while the average volume is about 77,908 shares. The stock escalated +12.36% and finished the day at $0.300. The beta of the stock is recorded at 63.02. Axxess Pharma Inc. is a pharmaceutical company. It is engaged in marketing of dermatological, therapeutic nutritionals, pain management, and diagnostic products in Canada and abroad. In October 2013, the Company announced that it has incorporated a wholly owned subsidiary AllStar HealthBrands Inc.
For How Long AXXE’s Gloss will Attract Investors? Find out via this report
Gray Fox Petroleum Corp (OTCBB:GFOX) shares rose, +11.92percent from its previous close of $0.965 to close at $1.08. Traded with volume of 586,891 shares in the prior session and the average volume of the stock remained 77,816 shares. Gray Fox Petroleum Corp., formerly VIATECH CORP., is a development-stage company. The Company intends to provide interior design and architectural visualization, third dimensional (3D) rendering and architectural animation services.
Why Should Investors Buy GFOX After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)